Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Harbour BioMed, Moderna partner on immunotherapies development
Harbour BioMed and Moderna will focus on discovering and developing nucleic acid-based immunotherapies for selected oncology targets. Credit: mwoot from Pixabay.
Harbour BioMed and Moderna will focus on discovering and developing nucleic acid-based immunotherapies for selected oncology targets. Credit: mwoot from Pixabay.